MOESM3 of Characterization of Pb51 in Plasmodium berghei as a malaria vaccine candidate targeting both asexual erythrocytic proliferation and transmission

Additional file 3: Figure S3. Effects of passive received anti-rPb51 sera on asexual proliferation, gametocytogenesis and host survival. a The group that passively received sera from control group exhibited 1.52-fold higher parasitaemia than the rPb51-immunized group on day 9 post-infection. b Gametocytaemia in mice treated with PBS or passively received control sera or anti-rPb51 sera. c The group passively received anti-rPb51 sera survived for 4 days longer than the control group, and 5 days longer than the group passively received control sera injected with PBS. For a-c, the data represent results from three separate experiments. Error bars indicate mean ± SD. *P< 0.05, **P< 0.01 (Student’s t test)